Craneware (CRW) Share Price, News & Analysis

Company Overview

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

Key Stats

• Today's Range: 2,247.30 to 2,250
• 50-Day Range: 1,779.24 to 2,247.30
• 52-Week Range: 1,330 to 2,491.20
• Volume: 22,912 shs
• Average Volume: 79,097 shs
• Market Capitalization: £965.59 million
• P/E Ratio: 83.03
• Dividend Yield: 1.29%
• Price Target: GBX 2,800
• Consensus Rating: Buy

CRW Stock Analysis - Frequently Asked Questions

How have CRW shares performed this year?

Craneware's stock was trading at GBX 2,110 at the beginning of 2025. Since then, CRW stock has increased by 6.5% and is now trading at GBX 2,247.30.

How do I buy shares of Craneware?

Shares of CRW stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Craneware own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Craneware investors own include Rolls-Royce Holdings plc (RR.L), accesso Technology Group (ACSO), Greencore Group (GNC), Nikola (NKLA), ASOS (ASC), Babcock International Group (BAB) and ChargePoint (CHPT).

Company Calendar

• Record date for 4/17 Dividend: 3/20/2025
• Ex-Dividend for 4/17 Dividend: 3/20/2025
• Dividend Payable: 4/17/2025
• Today: 7/07/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: LON:CRW
• CIK: N/A
• Web: public.craneware.com
• Phone: +44-131-5503100
• Fax: N/A
• Employees: 734
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 2,800
• High Stock Price Target: GBX 2,800
• Low Stock Price Target: GBX 2,800
• Potential Upside/Downside: +24.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 27.07
• Trailing P/E Ratio: 83.03
• Forward P/E Ratio: 28.60
• P/E Growth: N/A
• Net Income: £14.27 million
• Net Margins: 6.18%
• Pretax Margin: N/A
• Return on Equity: 3.58%
• Return on Assets: 2.28%

Debt

• Debt-to-Equity Ratio: 12.22
• Current Ratio: 0.63
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: £230.77 million
• Price / Sales: 4.18
• Cash Flow: GBX 152.70 per share
• Price / Cash Flow: 14.72
• Book Value: GBX 932.46 per share
• Price / Book: 2.41

Miscellaneous

• Outstanding Shares: 42,966,569
• Free Float: N/A
• Market Cap: £965.59 million
• Optionable: Not Optionable
• Beta: 0.28